Sandra P. McCurdy
Melinta Therapeutics (United States)(US)
Publications by Year
Research Areas
Antimicrobial Resistance in Staphylococcus, Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Bacterial Identification and Susceptibility Testing, Pneumonia and Respiratory Infections
Most-Cited Works
- → Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor(2003)668 cited
- → Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response(2002)486 cited
- → Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection(2010)332 cited
- → The Novel JAK-3 Inhibitor CP-690550 Is a Potent Immunosuppressive Agent in Various Murine Models(2003)154 cited
- → Multicity Outbreak of Linezolid‐ResistantStaphylococcus epidermidisAssociated with Clonal Spread of acfr‐Containing Strain(2010)94 cited
- → In Vitro Activity of Delafloxacin and Microbiological Response against Fluoroquinolone-Susceptible and Nonsusceptible Staphylococcus aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections(2017)85 cited
- → 5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV(2009)74 cited
- → Pyridone-Conjugated Monobactam Antibiotics with Gram-Negative Activity(2013)63 cited
- → Successful Eradication of a Monoclonal Strain ofKlebsiella pneumoniaeduring aK. pneumoniaeCarbapenemase-ProducingK. pneumoniaeOutbreak in a Surgical Intensive Care Unit in Miami, Florida(2010)62 cited
- → Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV(2013)56 cited